Hidradenitis Suppurativa (HS)
Incyte Hidradenitis Suppurativa (HS) (INCB054707-801) ON-LONVIC
Posted 2 weeks ago
Learn more →
Explore leading-edge treatment opportunities. See open studies
Help advance medicine and access innovative care
Contribute to medical breakthroughs that change lives
Join a Study at
Centricity Research
Our Study Finder connects you with clinical trials that match your condition and interests, giving you the opportunity to access potential new treatments while helping advance medical research for future generations.
How it works
Four simple steps to participate
Joining a clinical trial is easier than you think. Here’s what to expect.
Step 1
Pre-qualify online
Answer a few questions to find studies you may be eligible for.
Step 2
Talk with our team
Our coordinators reach out to confirm fit and schedule a screening visit.
Step 3
Participate in the study
Receive expert care, study medication, and ongoing health monitoring.
Step 4
Make a difference
Help bring new treatments to the millions who need them most.
01
Access to new treatment options
02
Compensation for particpation
03
No cost for study related care
Why participate
Benefits of participating
04
Higher level of health care
05
Advancement of medical science
06
No insurance needed
Why Participate
There’s more than one reason to Participate
Get paid for time and travel
Learn about new medicines in development
Help bring new treatments to people who need them
No cost for study related care
No insurance needed
Care from licensed medical professionals
Currently recruiting
Upcoming & active studies
About CLINICAL Research
Clinical trials across many therapeutic areas
Centricity Research specializes in conducting clinical trials across multiple therapeutic areas, ranging from oncology, cardiology, endocrinology, infectious diseases, and more.
Our team of experienced professionals are dedicated to helping you find the right clinical study for your needs. Learn more about our open studies and what clinical trial opportunities may be right for you.
500K+
Patients enrolled
22+
Therapeutic areas
2,000+
Trials conducted
24+
Research sites
